Tea benefits your health and longevity — how you drink it matters

A new international study examining the effects of regular tea consumption on health and longevity has been published, summarized by Science Daily. Drawing on three decades of follow-up data, the study reported lower cardiovascular mortality risk among adults who drank two to three cups of tea a day.
The research team pooled data on more than 600,000 participants from large cohort studies in China, the United Kingdom and the United States. The dataset covered both black and green tea drinkers and adjusted for coffee intake and confounders such as calories, physical activity and smoking.
Tea is rich in catechins and flavonoids — compounds with antioxidant effects that can positively influence vascular wall function. The lead author said the effect size was small but consistent, and the mechanism is likely linked to reduced LDL cholesterol oxidation and lower-grade chronic inflammation.
The dose-response curve is not linear. Risk reduction was most pronounced in the two-to-three-cup-a-day range. Above five cups, the benefit plateaus and, depending on individual sensitivity, sleep disruption and caffeine-related side effects may emerge. The researchers explicitly reject a 'more is better' framing.
Preparation method matters. Hot infusions tend to deliver higher catechin concentrations than cold brews or iced teas. For bagged or loose-leaf teas, a brewing time of three to five minutes brings polyphenol yield close to optimal.
Adding milk produces a measurable effect. Milk proteins can bind to tea polyphenols, lowering bioavailability; the result was not an erasure of benefit but a smaller effect size. Adding sugar, by contrast, lifts caloric intake and metabolically pulls in the opposite direction.
Study limitations were reported transparently. The data are largely observational, and causality requires randomized trials. Consumption frequency relies on participant questionnaires, which may not fully match day-to-day reality. Even so, the effect size held up consistently across subgroups.
Public-health experts frame the evidence as supporting tea as 'part of an overall healthy lifestyle' rather than a drug-like intervention. In expert commentary cited by Science Daily, Harvard epidemiologist Dr Yan Zheng said: 'It would be misleading to focus only on tea intake while ignoring diet quality and physical activity.'
Current dietary guidance in most countries already describes tea as 'one of the preferred fluid sources.' The study's findings support that framing while flagging that late-evening consumption may disrupt sleep due to caffeine.
Future studies are expected to define more specific doses for matcha, oolong and white tea. For now, the most practical takeaway is that two to three cups a day, with little or no sugar and ideally plain, can be a sustainable addition to a balanced diet. This is not medical advice; consult your doctor on diet and health decisions.
Read next

World's largest opioid review finds they often do not work
The largest review yet of opioid use in chronic pain has concluded that the drugs often deliver disappointing results across many clinical situations, Science Daily reports. The researchers say prescribing practices should be revisited.

Doctors and the NHS could be sued for mistakes made by AI tools, report warns
According to the Guardian, a new Medical Protection Society report finds that doctors and NHS services could be sued over mistakes made by AI tools used in clinical practice. The report calls for an urgent update to insurance and liability frameworks.

Weight-loss drugs drive global whey protein supply toward shortage
Global demand for whey protein is hitting record levels as millions of patients on GLP-1 weight-loss drugs turn to high-protein diets to offset muscle loss, the Guardian reports. Suppliers say production capacity is already pushed close to its limits.

FDA approves first new sunscreen ingredient in over 25 years
The US Food and Drug Administration has cleared bemotrizinol, a broad-spectrum UVA-UVB filter long used in Europe, for the American market. As reported by STAT News, it is the first new sunscreen active ingredient to receive FDA approval since 1999.

Advanced prostate cancer radiotherapy to cut sessions from 20 to five
England's NHS has approved a high-precision radiotherapy schedule for prostate cancer that compresses treatment from 20 sessions over four weeks to five sessions in a week and a half. The BBC reports the change will affect about 10,000 men a year and cut hospital trips by two-thirds.
